Thank you Stephen for setting me up on this site.
We are evaluating clinical trials to select one for my mother's GBM treatment. She has not yet started on radiation and Tamodar after the surgery.
Does anyone on this forum have experience with ICT-107 vaccine (randomized with 50% placebo) or DC Vaccine (phase 1) or stem cell based protocol (personalized by UCSF)? We have to choose one of these three this week itself as it's bee 4 week since her surgery and we are running out of time. Any insights or pointers to help select one would be highly appreciated.
1)
Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
2)
Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
3)
An ex USCF doctor has offered to work with us on developing cell based high throughput cancer stem cell protocol.